SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-017582
Filing Date
2023-05-11
Accepted
2023-05-11 16:23:36
Documents
46
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q blcm-20230331.htm   iXBRL 10-Q 966133
2 EX-31.1 a2023q1exhibit311.htm EX-31.1 11804
3 EX-32.1 a2023q1exhibit321.htm EX-32.1 5558
  Complete submission text file 0001628280-23-017582.txt   4011742

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20230331.xsd EX-101.SCH 31483
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20230331_cal.xml EX-101.CAL 33873
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20230331_def.xml EX-101.DEF 133673
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20230331_lab.xml EX-101.LAB 359453
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20230331_pre.xml EX-101.PRE 230816
40 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20230331_htm.xml XML 513768
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36783 | Film No.: 23911412
SIC: 2834 Pharmaceutical Preparations